It’s early January 2020, and a mysterious new virus is overtaking the city of Wuhan, China. At first the outbreak barely makes the news, but as the threat comes into focus, scientists spring into action to make a vaccine. But the outlook’s grim – vaccines take years to create, test and approve. No one expects one to arrive anytime soon. But for two ambitious biotech start-ups, this is a chance to show the world what their cutting-edge tech can do. Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars. Support us by supporting our sponsors!  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials. But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the world. All of which costs a lot of moolah. And if the vaccine makers can’t secure a deep-pocketed partner in time, they’re going to get disqualified from the race. Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars. Support us by supporting our sponsors! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.